{
  "DOI": "10.1007/s12687-011-0060-2",
  "ISSN": [
    "1868-310X",
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-011-0060-2",
  "alternative-id": [
    "60"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Abraham",
      "given": "John",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Ballinger",
      "given": "Rachel",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2011,
        7,
        19
      ]
    ],
    "date-time": "2011-07-19T08:41:23Z",
    "timestamp": 1311064883000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        6,
        2
      ]
    ],
    "date-time": "2019-06-02T10:17:34Z",
    "timestamp": 1559470654000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        3,
        31
      ]
    ],
    "date-time": "2022-03-31T04:56:25Z",
    "timestamp": 1648702585861
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "print",
      "value": "1868-310X"
    },
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2011,
        7,
        20
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2012,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2011,
            7,
            20
          ]
        ],
        "date-time": "2011-07-20T00:00:00Z",
        "timestamp": 1311120000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s12687-011-0060-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s12687-011-0060-2/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s12687-011-0060-2",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "91-103",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2011,
        7,
        20
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2011,
        7,
        20
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2012,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "author": "J Abraham",
      "key": "60_CR1",
      "unstructured": "Abraham J (1995) Science, politics and the pharmaceutical industry. UCL/St Martin’s Press, London/New York",
      "volume-title": "Science, politics and the pharmaceutical industry",
      "year": "1995"
    },
    {
      "DOI": "10.1016/S0277-9536(97)00133-0",
      "author": "J Abraham",
      "doi-asserted-by": "crossref",
      "first-page": "39",
      "journal-title": "Soc Sci Med",
      "key": "60_CR2",
      "unstructured": "Abraham J (1998) Regulating the cancer-inducing potential of non-steroidal anti-inflammatory drugs: some lessons from the 1970s and 1980s. Soc Sci Med 46:39–51",
      "volume": "46",
      "year": "1998"
    },
    {
      "author": "J Abraham",
      "key": "60_CR3",
      "unstructured": "Abraham J, Lewis G (2000) Regulating medicines in Europe. Routledge, London",
      "volume-title": "Regulating medicines in Europe",
      "year": "2000"
    },
    {
      "DOI": "10.1080/713670172",
      "author": "J Abraham",
      "doi-asserted-by": "crossref",
      "first-page": "113",
      "journal-title": "Health Risk Soc",
      "key": "60_CR4",
      "unstructured": "Abraham J, Reed T (2001) Trading risks for markets: the international harmonisation of pharmaceuticals regulation. Health Risk Soc 3:113–128",
      "volume": "3",
      "year": "2001"
    },
    {
      "author": "Anon",
      "first-page": "14",
      "journal-title": "Scrip",
      "key": "60_CR5",
      "unstructured": "Anon (1992) ICH progress so far. Scrip 1707:14–15",
      "volume": "1707",
      "year": "1992"
    },
    {
      "DOI": "10.1177/096032719601500301",
      "author": "J Ashby",
      "doi-asserted-by": "crossref",
      "first-page": "183",
      "journal-title": "Hum Exp Toxicol",
      "key": "60_CR6",
      "unstructured": "Ashby J (1996) Alternatives to the 2-species bioassay for the identification of potential human carcinogens. Hum Exp Toxicol 15:183–202",
      "volume": "15",
      "year": "1996"
    },
    {
      "DOI": "10.1016/0165-1110(91)90003-E",
      "author": "J Ashby",
      "doi-asserted-by": "crossref",
      "first-page": "229",
      "journal-title": "Mutat Res",
      "key": "60_CR7",
      "unstructured": "Ashby J, Tennant RW (1991) Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the US National Toxicology Programme. Mutat Res 257:229–306",
      "volume": "257",
      "year": "1991"
    },
    {
      "author": "P Bentley",
      "first-page": "111",
      "key": "60_CR8",
      "unstructured": "Bentley P, Baier H, Krug E (1992) Results from carcinogenicity tests in two rodent species - do they improve or confuse decision-making? An industry viewpoint. In: McAuslane JAN, Lumley CE, Walker SR (eds) The carcinogenicity debate. Quay Publishing, Carshalton, Surrey, pp 111–120",
      "volume-title": "The carcinogenicity debate",
      "year": "1992"
    },
    {
      "author": "Centre for Medicines Research (CMR)",
      "key": "60_CR9",
      "unstructured": "Centre for Medicines Research (CMR) (1995) Annual report for 1995. CMR, Carshalton, Surrey",
      "volume-title": "Annual report for 1995",
      "year": "1995"
    },
    {
      "author": "CoC",
      "first-page": "254",
      "journal-title": "Toxicol Pathol",
      "key": "60_CR10",
      "unstructured": "CoC (2003) Statement on ILSI/HESI research programme on alternative cancer models. Toxicol Pathol 31:254–257",
      "volume": "31",
      "year": "2003"
    },
    {
      "DOI": "10.1093/toxsci/64.1.14",
      "author": "SM Cohen",
      "doi-asserted-by": "crossref",
      "first-page": "14",
      "journal-title": "Toxicol Sci",
      "key": "60_CR11",
      "unstructured": "Cohen SM, Robinson D, MacDonlad JS (2001) Alternative models for carcinogenicity testing. Toxicol Sci 64:14–19",
      "volume": "64",
      "year": "2001"
    },
    {
      "DOI": "10.1177/019262339602400422",
      "author": "JF Contrera",
      "doi-asserted-by": "crossref",
      "first-page": "514",
      "journal-title": "Toxicol Pathol",
      "key": "60_CR12",
      "unstructured": "Contrera JF (1996) FDA science symposium: developing alternative in vivo approaches for the assessment of carcinogenicity: background and objectives. Toxicol Pathol 24:514",
      "volume": "24",
      "year": "1996"
    },
    {
      "DOI": "10.1006/rtph.1997.1085",
      "author": "JF Contrera",
      "doi-asserted-by": "crossref",
      "first-page": "130",
      "journal-title": "Regul Toxicol Pharmacol",
      "key": "60_CR13",
      "unstructured": "Contrera JF, Jacobs AC, DeGeorge JJ (1997) Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals. Regul Toxicol Pharmacol 25:130–145",
      "volume": "25",
      "year": "1997"
    },
    {
      "DOI": "10.1111/j.1539-6924.1989.tb01236.x",
      "author": "JC Cordaro",
      "doi-asserted-by": "crossref",
      "first-page": "157",
      "journal-title": "Risk Anal",
      "key": "60_CR14",
      "unstructured": "Cordaro JC (1989) Transgenic mice as future tools in risk assessment. Risk Anal 9:157–168",
      "volume": "9",
      "year": "1989"
    },
    {
      "key": "60_CR15",
      "unstructured": "D’Arcy PF, Harron DWG (eds) (1996) Proceedings of the third international conference on harmonisation. Queen’s University Belfast, Belfast",
      "volume-title": "Proceedings of the third international conference on harmonisation",
      "year": "1996"
    },
    {
      "author": "J DeGeorge",
      "first-page": "274",
      "key": "60_CR16",
      "unstructured": "DeGeorge J (1996) A regulatory perspective of the guidance on the utility of two rodent species. In: D’Arcy PF, Harron DWG (eds) Proceedings of the third international conference on harmonisation. Queen’s University Belfast, Belfast, pp 274–277",
      "volume-title": "Proceedings of the third international conference on harmonisation",
      "year": "1996"
    },
    {
      "key": "60_CR17",
      "unstructured": "Department of Health (1997) Annual Report of the Committee on Toxicity, Mutagenicity, and Carcinogenicity of Chemicals in Food, Consumer Products and the Environment"
    },
    {
      "author": "B Easlea",
      "key": "60_CR18",
      "unstructured": "Easlea B (1973) Liberation and the aims of science. Scottish Academic Press, Edinburgh",
      "volume-title": "Liberation and the aims of science",
      "year": "1973"
    },
    {
      "DOI": "10.1080/019262301753178483",
      "author": "WC Eastin",
      "doi-asserted-by": "crossref",
      "first-page": "60",
      "issue": "suppl",
      "journal-title": "Toxicol Pathol",
      "key": "60_CR19",
      "unstructured": "Eastin WC, Mennear JH, Tennant RW, Stoll RE, Branstetter GE, Bucher JR, McCullough B, Binder RL, Spalding JW, Mahier JF (2001) TgAC genetically altered mouse: assay working group overview of available data. Toxicol Pathol 29(suppl):60–80",
      "volume": "29",
      "year": "2001"
    },
    {
      "author": "L Ekman",
      "first-page": "295",
      "key": "60_CR20",
      "unstructured": "Ekman L (1996) Panel discussion. In: D’Arcy PF, Harron DWG (eds) Proceedings of the third international conference on harmonisation. Queen’s University Belfast, Belfast, pp 295–302",
      "volume-title": "Proceedings of the third international conference on harmonisation",
      "year": "1996"
    },
    {
      "author": "JL Emmerson",
      "first-page": "202",
      "key": "60_CR21",
      "unstructured": "Emmerson JL (1992) High dose selection in the design of studies to evaluate the carcinogenic potential of pharmaceutical: industry perspectives. In: D’Arcy PF, Harron DWG (eds) Proceedings of the first international conference on harmonisation. Queen’s University Belfast, Belfast, pp 202–208",
      "volume-title": "Proceedings of the first international conference on harmonisation",
      "year": "1992"
    },
    {
      "DOI": "10.1289/ehp.95103680",
      "author": "VA Fung",
      "doi-asserted-by": "crossref",
      "first-page": "680",
      "journal-title": "Environ Heal Perspect",
      "key": "60_CR22",
      "unstructured": "Fung VA, Barrett JC, Huff J (1995) The carcinogenesis bioassay in perspective: application in identifying human cancer hazards. Environ Heal Perspect 103:680–683",
      "volume": "103",
      "year": "1995"
    },
    {
      "author": "GeneWatch",
      "key": "60_CR23",
      "unstructured": "GeneWatch (2002) Genetically modified and cloned animals. All in a good cause? GeneWatch, London",
      "volume-title": "Genetically modified and cloned animals. All in a good cause?",
      "year": "2002"
    },
    {
      "DOI": "10.1080/019262301753178582",
      "author": "JI Goodman",
      "doi-asserted-by": "crossref",
      "first-page": "173",
      "journal-title": "Toxicol Pathol",
      "key": "60_CR24",
      "unstructured": "Goodman JI (2001) A perspective on current and future uses of alternative models for carcinogenicity testing. Toxicol Pathol 29:173–176",
      "volume": "29",
      "year": "2001"
    },
    {
      "DOI": "10.1111/1467-9310.00042",
      "author": "RG Halliday",
      "doi-asserted-by": "crossref",
      "first-page": "63",
      "journal-title": "R \u0026 D Manag",
      "key": "60_CR25",
      "unstructured": "Halliday RG, Drasdo AL, Lumley CE, Walker SR (1997) The allocation of resources for R \u0026 D in the world’s leading pharmaceutical companies. R \u0026 D Manag 27:63–77",
      "volume": "27",
      "year": "1997"
    },
    {
      "author": "Y Hayashi",
      "first-page": "291",
      "key": "60_CR26",
      "unstructured": "Hayashi Y (1994) Utility of two rodent species: current regulatory perspectives. In: D’Arcy PF, Harron DWG (eds) Proceedings of the second international conference on harmonisation. Queen’s University Belfast, Belfast, pp 291–293",
      "volume-title": "Proceedings of the second international conference on harmonisation",
      "year": "1994"
    },
    {
      "author": "IFPMA",
      "key": "60_CR27",
      "unstructured": "IFPMA (2000) The value and benefits of ICH to industry. IFPMA, Geneva",
      "volume-title": "The value and benefits of ICH to industry",
      "year": "2000"
    },
    {
      "author": "RJB King",
      "key": "60_CR28",
      "unstructured": "King RJB (1996) Cancer biology. Longman, Harlow, Essex",
      "volume-title": "Cancer biology",
      "year": "1996"
    },
    {
      "DOI": "10.1017/CBO9780511490934.008",
      "author": "D Laws",
      "doi-asserted-by": "crossref",
      "first-page": "172",
      "key": "60_CR29",
      "unstructured": "Laws D, Rein M (2003) Reframing practice. In: Hajer MA, Wagenaar H (eds) Deliberative policy analysis: understanding governance in the network society. Cambridge University Press, Cambridge, pp 172–206",
      "volume-title": "Deliberative policy analysis: understanding governance in the network society",
      "year": "2003"
    },
    {
      "key": "60_CR30",
      "unstructured": "Lumley CE, Van Cauteren H (1997) Harmonisation of international toxicity testing guidelines for pharmaceuticals: contribution to refinement and reduction in animal use. European Biological Research Association Bulletin, November (reprinted)"
    },
    {
      "author": "JS MacDonald",
      "first-page": "272",
      "key": "60_CR31",
      "unstructured": "MacDonald JS (1998) Evaluation of mew models II. In: D’Arcy PF, Harron DWG (eds) Proceedings of the fourth international conference on harmonisation. Queen’s University Belfast, Belfast, pp 272–277",
      "volume-title": "Proceedings of the fourth international conference on harmonisation",
      "year": "1998"
    },
    {
      "author": "K Mitsumori",
      "first-page": "263",
      "key": "60_CR32",
      "unstructured": "Mitsumori K (1998) Evaluation of new models I: initiation and promotion models and the Hras 2 mouse model. In: D’Arcy PF, Harron DWG (eds) Proceedings of the fourth international conference on harmonisation. Queen’s University Belfast, Belfast, pp 263–271",
      "volume-title": "Proceedings of the fourth international conference on harmonisation",
      "year": "1998"
    },
    {
      "author": "A Monro",
      "first-page": "25",
      "key": "60_CR33",
      "unstructured": "Monro A (1992) Why do chemicals apparently cause tumours more readily in rodents than in humans: biology or exposure? In: McAuslane JAN, Lumley CE, Walker SR (eds) The carcinogenicity debate. Quay Publishing, Carshalton, Surrey, pp 25–44",
      "volume-title": "The carcinogenicity debate",
      "year": "1992"
    },
    {
      "author": "AM Monro",
      "first-page": "293",
      "key": "60_CR34",
      "unstructured": "Monro AM (1994) Utility of two rodent species: some arguments for and against. In: D’Arcy PF, Harron DWG (eds) Proceedings of the second international conference on harmonisation. Queen’s University Belfast, Belfast, pp 293–300",
      "volume-title": "Proceedings of the second international conference on harmonisation",
      "year": "1994"
    },
    {
      "author": "A Monro",
      "first-page": "260",
      "key": "60_CR35",
      "unstructured": "Monro A (1996) Testing for carcinogenic potential: Rapporteur’s report. In: D’Arcy PF, Harron DWG (eds) Proceedings of the third international conference on harmonisation. Queen’s University Belfast, Belfast, pp 260–268",
      "volume-title": "Proceedings of the third international conference on harmonisation",
      "year": "1996"
    },
    {
      "author": "B Mulliger",
      "first-page": "16",
      "issue": "Spring",
      "journal-title": "CMR News",
      "key": "60_CR36",
      "unstructured": "Mulliger B (1997) Science should drive regulatory decisions, advise carcinogenicity workshop participants. CMR News 16(Spring):16–19",
      "volume": "16",
      "year": "1997"
    },
    {
      "DOI": "10.1177/096032719301200202",
      "author": "C Parkinson",
      "doi-asserted-by": "crossref",
      "first-page": "99",
      "journal-title": "Hum Exp Toxicol",
      "key": "60_CR37",
      "unstructured": "Parkinson C, Grasso P (1993) The use of the dog in toxicity tests on pharmaceutical compounds. Hum Exp Toxicol 12:99–109",
      "volume": "12",
      "year": "1993"
    },
    {
      "DOI": "10.1080/019262301753178618",
      "author": "SD Pettit",
      "doi-asserted-by": "crossref",
      "first-page": "191",
      "journal-title": "Toxicol Pathol",
      "key": "60_CR38",
      "unstructured": "Pettit SD (2001) Panel discussion on the application of alternative models to cancer risk assessment. Toxicol Pathol 29:191–195",
      "volume": "29",
      "year": "2001"
    },
    {
      "author": "I Purchase",
      "first-page": "3",
      "key": "60_CR39",
      "unstructured": "Purchase I (1992) Current knowledge of mechanisms of carcinogenicity: genotoxins versus non-genotoxins. In: McAuslane JAN, Lumley CE, Walker SR (eds) The carcinogenicity debate. Quay Publishing, Carshalton, Surrey, pp 3–24",
      "volume-title": "The carcinogenicity debate",
      "year": "1992"
    },
    {
      "author": "F Roe",
      "first-page": "103",
      "key": "60_CR40",
      "unstructured": "Roe F (1992) Factors affecting the duration of carcinogenicity studies: when should they end? In: McAuslane JAN, Lumley CE, Walker SR (eds) The carcinogenicity debate. Quay Publishing, Carshalton, Surrey, pp 103–109",
      "volume-title": "The carcinogenicity debate",
      "year": "1992"
    },
    {
      "author": "D Scales",
      "first-page": "129",
      "key": "60_CR41",
      "unstructured": "Scales D, Griffin J (1992) Use of two matched strains: can they improve sensitivty? In: McAuslane JAN, Lumley CE, Walker SR (eds) The carcinogenicity debate. Quay Publishing, Carshalton, Surrey, pp 129–139",
      "volume-title": "The carcinogenicity debate",
      "year": "1992"
    },
    {
      "author": "JS Schou",
      "first-page": "208",
      "key": "60_CR42",
      "unstructured": "Schou JS (1992) Predictive value of carcinogenicity studies for drug safety. In: D’Arcy PF, Harron DWG (eds) Proceedings of the first international conference on harmonisation. Queens University Belfast, Belfast, pp 208–212",
      "volume-title": "Proceedings of the first international conference on harmonisation",
      "year": "1992"
    },
    {
      "author": "J Schumpeter",
      "key": "60_CR43",
      "unstructured": "Schumpeter J (1942) Capitalism, socialism and democracy. Harper \u0026 Row, New York",
      "volume-title": "Capitalism, socialism and democracy",
      "year": "1942"
    },
    {
      "DOI": "10.1080/10915810252826028",
      "author": "FD Sistare",
      "doi-asserted-by": "crossref",
      "first-page": "65",
      "journal-title": "Int J Toxicol",
      "key": "60_CR44",
      "unstructured": "Sistare FD, Thompson KL, Honchel R, DeGeorge JJ (2002) Evaluation of the TgAC transgenic mouse assay for testing the human carcinogenic potential of pharmaceuticals—practical pointers, mechanistic clues, and new questions. Int J Toxicol 21:65–79",
      "volume": "21",
      "year": "2002"
    },
    {
      "DOI": "10.1080/019262301753178465",
      "author": "R Storer",
      "doi-asserted-by": "crossref",
      "first-page": "30",
      "issue": "suppl",
      "journal-title": "Toxicol Pathol",
      "key": "60_CR45",
      "unstructured": "Storer R, French JE, Haseman JK, Hajian G, LeGrand EK, Long GG, Mixson LA, Ochoa R (2001) P53 hemizygous knock-out mouse: overview of available data. Toxicol Pathol 29(suppl):30–50",
      "volume": "29",
      "year": "2001"
    },
    {
      "author": "RW Tennant",
      "first-page": "516",
      "journal-title": "Toxicol Pathol",
      "key": "60_CR46",
      "unstructured": "Tennant RW (1996) FDA science symposium: developing alternative in vivo approaches for the assessment of carcinogenicity. Toxicol Pathol 25:516",
      "volume": "25",
      "year": "1996"
    },
    {
      "DOI": "10.1289/ehp.95103942",
      "author": "RW Tennant",
      "doi-asserted-by": "crossref",
      "first-page": "942",
      "journal-title": "Environ Heal Perspect",
      "key": "60_CR47",
      "unstructured": "Tennant RW, French JE, Spalding JW (1995) Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ Heal Perspect 103:942–950",
      "volume": "103",
      "year": "1995"
    },
    {
      "author": "T Usui",
      "first-page": "279",
      "key": "60_CR48",
      "unstructured": "Usui T, Griffiths SA, Lumley CE (1996) Industry viewpoint: the utility of the mouse for the assessment of the carcinogenic potential of pharmaceuticals. In: D’Arcy PF, Harron DWG (eds) Proceedings of the third international conference on harmonisation. Queen’s University Belfast, Belfast, pp 279–284",
      "volume-title": "Proceedings of the third international conference on harmonisation",
      "year": "1996"
    },
    {
      "DOI": "10.1080/019262301753178500",
      "author": "T Usui",
      "doi-asserted-by": "crossref",
      "first-page": "90",
      "issue": "suppl",
      "journal-title": "Toxicol Pathol",
      "key": "60_CR49",
      "unstructured": "Usui T, Mutai M, Hisada S, Takoaka M, Soper KA, McCullough B, Alden C (2001) CB6F1-rasH2 mouse: overview of available data. Toxicol Pathol 29(suppl):90–108",
      "volume": "29",
      "year": "2001"
    },
    {
      "DOI": "10.1006/rtph.2001.1505",
      "author": "JW Laan Van der",
      "doi-asserted-by": "crossref",
      "first-page": "122",
      "journal-title": "Regul Toxicol Pharmacol",
      "key": "60_CR50",
      "unstructured": "Van der Laan JW, Spindler P (2002) The in vivo rodent test systems for assessment of carcinogenic potential. Regul Toxicol Pharmacol 35:122–125",
      "volume": "35",
      "year": "2002"
    },
    {
      "DOI": "10.1080/019262301301418928",
      "author": "CF Kreijl Van",
      "doi-asserted-by": "crossref",
      "first-page": "117",
      "issue": "suppl",
      "journal-title": "Toxicol Pathol",
      "key": "60_CR51",
      "unstructured": "Van Kreijl CF, McAnulty PA, Beems RB, Vynckier A, van Steeg H, Fransson-Steen R, Alden C, Forster R, van der Laan JW, Vandenberghe J (2001) Xpa and Xpa/p53 knock-out mice: overview of available data. Toxicol Pathol 29(suppl):117–127",
      "volume": "29",
      "year": "2001"
    },
    {
      "DOI": "10.1006/rtph.1996.1077",
      "author": "JPJ Oosterhout Van",
      "doi-asserted-by": "crossref",
      "first-page": "6",
      "journal-title": "Regul Toxicol Pharmacol",
      "key": "60_CR52",
      "unstructured": "Van Oosterhout JPJ, Van der Laan JW, Waal EJ, Olejniczak K, Hilgenfeld M, Schmidt V, Bass R (1997) The utility of two rodent species in carcinogenic risk assessment of pharmaceuticals in Europe. Regul Toxicol Pharmacol 25:6–17",
      "volume": "25",
      "year": "1997"
    },
    {
      "author": "J Weissinger",
      "first-page": "73",
      "key": "60_CR53",
      "unstructured": "Weissinger J (1992) Factors affecting the duration of carcinogenicity studies: when should a study end?—A regulatory viewpoint. In: McAuslane JAN, Lumley CE, Walker SR (eds) The carcinogenicity debate. Quay Publishing, Carshalton, Surrey, pp 73–76",
      "volume-title": "The carcinogenicity debate",
      "year": "1992"
    },
    {
      "author": "WHO",
      "first-page": "426",
      "key": "60_CR54",
      "unstructured": "WHO (1969) Principles for the testing and evaluation of drugs for carcinogenicity. WHO, Geneva, p 426, Technical Report Series",
      "volume-title": "Principles for the testing and evaluation of drugs for carcinogenicity",
      "year": "1969"
    },
    {
      "DOI": "10.1007/978-94-009-3221-0_5",
      "author": "G Zbinden",
      "doi-asserted-by": "crossref",
      "first-page": "49",
      "key": "60_CR55",
      "unstructured": "Zbinden G (1987) Risk predicted from animal studies. In: Walker SR, Asscher WA (eds) Medicines and risk/benefit decisions. MTP Press, Lancaster, pp 49–56",
      "volume-title": "Medicines and risk/benefit decisions",
      "year": "1987"
    }
  ],
  "reference-count": 55,
  "references-count": 55,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s12687-011-0060-2"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "Power, expertise and the limits of representative democracy: genetics as scientific progress or political legitimation in carcinogenic risk assessment of pharmaceuticals?"
  ],
  "type": "journal-article",
  "volume": "3"
}